SecBot SecBot
SECBOTREPLAY Home › Report › ABCL

ABCL · Three AbCellera insiders, including the CFO and two directors,…

AbCellera Biologics Inc. · CLUSTER filed Aug 18, 2026 at 14:45 ET

At the news

BULLISHIMPACT 5/10

CLUSTER filed Aug 18, 2026 at 14:45 ET

Three AbCellera insiders, including the CFO and two directors, purchased a total of ~$975K in open-market shares over a 7-day window following a $200M dilutive offering and positive Phase 2 data for ABCL635. The cluster buys, particularly the CFO's $384K purchase, signal insider confidence in the pipeline despite the recent capital raise dilution. At ~0.03% of market cap, the dollar amount is modest but the C-suite participation and proximity to a catalyst make this a notable bullish signal.

  • CFO Andrew Booth bought $384K in open-market shares on 2026-08-14 at $10.32
  • Director Michael R. Hayden bought $481K on 2026-08-12 at $10.37
  • Director John S. Montalbano bought $110K on 2026-08-18 at $11.03
  • Total insider purchases of ~$975K represent ~0.03% of $3.3B market cap

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access